Cite
HARVARD Citation
Bertucci, F. et al. (2022). Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Journal for immunotherapy of cancer. 10 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bertucci, F. et al. (2022). Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Journal for immunotherapy of cancer. 10 (1), p. . [Online].